| Predicate |
Object |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
| filingDate |
2019-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109776607-B |
| titleOfInvention |
Aryl phosphorus oxygen and aryl phosphorus sulfur compounds, and preparation method and application thereof |
| abstract |
The aryl phosphorus oxygen compound and the aryl phosphorus sulfur compound can be used as an HIF-2 alpha inhibitor and used for preparing medicaments for treating and/or preventing diseases or symptoms related to hypoxia inducible factor 2 alpha of mammals. The structural formulas of the aryl phosphorus oxygen compound and the aryl phosphorus sulfur compound are as follows: |
| priorityDate |
2019-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |